What is the role of Ampyra in MS patients?

(Post date: 12/19/2014)

What is the role of dalfampridine (Ampyra) in multiple sclerosis patients? We asked four clinicians to comment: Brian Weinshenker, MD, of the Mayo Clinic in Rochester, Minn.; Neil Lava, MD, of Emory University in Atlanta; Andrew Goodman, MD, of the University of Rochester’s Multiple Sclerosis Center; and Lana Zhovtis Ryerson, MD, of NYU Langone Medical Center’s Multiple Sclerosis Comprehensive Care Center in New York City. The drug boosts walking ability in some patients, our panel agreed; trying it for a few weeks will identify those who respond without marked adverse effects.

Watch a video presentation on this subject by clicking here